Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
February 14, 2024	By:	/s/ FLAVIA H. PEASE
	Flavia H. Pease
	Corporate Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.


Signatures		Title	Date
By:	/s/ JAMES C. FOSTER	Chairman, President and Chief Executive Officer	February 14, 2024
	James C. Foster

By:	/s/ FLAVIA H. PEASE	Corporate Executive Vice President and	February 14, 2024
	Flavia H. Pease	Chief Financial Officer

By:	/s/ MICHAEL G. KNELL	Corporate Senior Vice President and	February 14, 2024
	Michael G. Knell	Chief Accounting Officer

By:	/s/ NANCY C. ANDREWS	Director	February 14, 2024
	Nancy C. Andrews

By:	/s/ ROBERT J. BERTOLINI	Director	February 14, 2024
	Robert J. Bertolini

By:	/s/ RESHEMA KEMPS-POLANCO	Director	February 14, 2024
	Reshema Kemps-Polanco

By:	/s/ DEBORAH T. KOCHEVAR	Director	February 14, 2024
	Deborah T. Kochevar

By:	/s/ GEORGE LLADO	Director	February 14, 2024
	George Llado

By:	/s/ MARTIN MACKAY	Director	February 14, 2024
	Martin Mackay

By:	/s/ GEORGE E. MASSARO	Director	February 14, 2024
	George E. Massaro

By:	/s/ C. RICHARD REESE	Director	February 14, 2024
	C. Richard Reese

By:	/s/ CRAIG B. THOMPSON	Director	February 14, 2024
	Craig B. Thompson

By:	/s/ RICHARD F. WALLMAN	Director	February 14, 2024
	Richard F. Wallman

By:	/s/ VIRGINIA M. WILSON	Director	February 14, 2024
	Virginia M. Wilson

Previous: Item 15. (a)(3) and Item 15(b) Exhibits